2m 2m 2m 2m 2m 2m 2m
Jushi Hldgs-B-SV (JUSHF)
OTC
$0.47-$0.03 (-6.51%)
Price as of Jun 03, 2026- $97.0MMarket Cap
- 61.31%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Jushi Hldgs-B-SV (JUSHF)
$0.47-$0.03 (-6.51%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 262.9M +2.09% | 257.5M -4.42% | 269.4M -5.22% | 284.3M N/A | |
Cost of Revenue | 148.9M +6.97% | 139.2M -9.13% | 153.2M -18.85% | 188.8M N/A | |
Gross Profit | 114.0M -3.66% | 118.3M +1.79% | 116.2M +21.73% | 95.5M N/A | |
Sales and Marketing Expense | 109.1M +1.98% | 107.0M -3.14% | 110.5M -29.26% | 156.2M N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 31.0M +3.68% | 29.9M +12.42% | 26.6M +0.36% | 26.5M N/A | |
Total Operating Expenses | 109.1M +1.57% | 107.4M -9.75% | 119.0M -62.30% | 315.8M N/A | |
Operating Profit | 4.9M -55.34% | 10.9M +485.49% | -2.8M -98.72% | -220.3M N/A | |
Interest Income | 456,000 -18.13% | 557,000 +512.09% | 91,000 -35.92% | 142,000 N/A | |
Interest Expense | -40.8M +9.14% | -37.4M +1.24% | -37.0M -18.92% | -45.6M N/A | |
Interest Income and Expense and Net | -40.4M +9.55% | -36.9M -0.02% | -36.9M -18.87% | -45.4M N/A | |
Total Nonoperating Income and Expense | -38.5M +37.29% | -28.0M -8.10% | -30.5M -215.20% | 26.5M N/A | |
Income before Taxes | -33.6M +95.97% | -17.1M -48.50% | -33.3M -82.83% | -193.9M N/A | |
Income Taxes | 35.0M +10.62% | 31.6M -0.55% | 31.8M +276.49% | 8.4M N/A | |
Extraordinary Items | 0 -100.00% | 432,000 -94.96% | 8.6M -94.63% | 159.6M N/A | |
Net Income | -68.6M +40.62% | -48.8M -25.08% | -65.1M -67.82% | -202.3M N/A | |
Net Income from Continuing Operations Applicable to Common | -68.6M +40.62% | -48.8M -25.08% | -65.1M -67.82% | -202.3M N/A | |
Basic EPS and Net Income | -0.35 +40.00% | -0.25 -24.24% | -0.33 -68.87% | -1.06 N/A | |
Diluted EPS and Net Income | -0.35 +40.00% | -0.25 -24.24% | -0.33 -77.08% | -1.44 N/A | |
Basic Weighted Average Shares | 195.2M +0.02% | 195.2M +0.20% | 194.8M +2.50% | 190.0M N/A | |
Diluted Weighted Average Shares | 195.2M +0.02% | 195.2M +0.20% | 194.8M -4.63% | 204.2M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 24.0M +23.19% | 19.5M -25.00% | 26.0M -0.65% | 26.2M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 24.0M +23.19% | 19.5M -25.00% | 26.0M -0.65% | 26.2M N/A | |
Total Current Assets | 68.3M -5.32% | 72.2M -11.62% | 81.6M +16.54% | 70.1M N/A | |
Accumulated Depreciation | 70.2M +28.45% | 54.6M +39.91% | 39.0M +60.48% | 24.3M N/A | |
Property and Plant and Equipment and Net | 143.3M -0.52% | 144.1M -9.55% | 159.3M -10.40% | 177.8M N/A | |
Total Long-Term Assets | 354.0M -3.84% | 368.2M -3.56% | 381.8M -16.88% | 459.3M N/A | |
Total Assets | 422.3M -4.08% | 440.3M -4.98% | 463.4M -12.46% | 529.3M N/A | |
Income Taxes Payable | 265,000 -88.47% | 2.3M -55.70% | 5.2M -93.27% | 77.1M N/A | |
Total Short-Term Debt | 0 -100.00% | 2.8M -96.81% | 86.5M +893.96% | 8.7M N/A | |
Total Current Liabilities | 66.2M -3.93% | 68.9M -57.59% | 162.5M +50.95% | 107.6M N/A | |
Total Long-Term Debt | 41.1M -77.59% | 183.4M +45.55% | 126.0M -30.19% | 180.6M N/A | |
Total Long-Term Liabilities | 471.5M +11.82% | 421.7M +36.66% | 308.6M -17.90% | 375.8M N/A | |
Total Liabilities | 537.7M +9.61% | 490.6M +4.15% | 471.0M -2.57% | 483.4M N/A | |
Retained Earnings | -627.2M +12.28% | -558.6M +9.57% | -509.8M +14.64% | -444.7M N/A | |
Total Stockholders Equity | -115.3M +129.61% | -50.2M +706.08% | -6.2M -113.18% | 47.3M N/A | |
Total Shares Outstanding | 199.7M +1.53% | 196.7M +0.03% | 196.6M -0.03% | 196.7M N/A | |
Cash Flow | |||||
Cash from Operating Activities | 17.7M -17.82% | 21.6M +750.06% | -3.3M -84.51% | -21.4M N/A | |
Capital Expenditures | 16.1M +241.76% | 4.7M -56.18% | 10.7M -81.11% | 56.9M N/A | |
Cash from Investing Activities | -13.2M +87.09% | -7.1M +10.56% | -6.4M -92.09% | -80.9M N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 767,000 +103.14% | -24.5M -276.37% | 13.9M -59.19% | 34.0M N/A | |
Financials Ratio | |||||
Gross Margin | 43.35% -5.63% | 45.94% +6.50% | 43.14% N/A | N/A N/A | |
Operating Margin | 1.85% -56.26% | 4.22% +503.31% | -1.05% N/A | N/A N/A | |
Return on Assets | -15.90% +47.31% | -10.79% -17.70% | -13.12% N/A | N/A N/A | |
Return on Equity | 82.85% -52.04% | 172.76% +154.46% | -317.21% N/A | N/A N/A | |
Revenue Growth | 2.09% +147.26% | -4.42% -15.25% | -5.22% N/A | N/A N/A | |
Current Ratio | 1.03 -1.44% | 1.05 +108.40% | 0.50 N/A | N/A N/A | |
Cash Ratio | 0.36 +28.24% | 0.28 +76.84% | 0.16 N/A | N/A N/A | |
Debt-to-Equity Ratio | -0.36 -90.38% | -3.71 -89.13% | -34.11 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.10 -76.99% | 0.42 -7.80% | 0.46 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow